了解Akkermansia muciniphila和性结肠炎的发展之间的关系的进展
Nie Xu1, Xiaoping Xiao1, Ying Ma1
1Department of Neonate, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Frontiers in pediatrics
|October 13, 2025
概括
阿克尔曼西亚菌 (AKK) 通过加强肠道屏障和调节免疫反应,在性结肠炎 (UC) 中起着至关重要的作用. 特定的AKK菌株对UC具有治疗潜力,但菌株选择是有效治疗的关键.
科学领域:
- 胃肠道学和微生物学
- 免疫学 免疫学 免疫学
- 肠道微生物组研究研究
背景情况:
- 性结肠炎 (UC) 涉及肠道屏障功能障碍和免疫失调,治疗选择有限.
- Akkermansia muciniphila (AKK) 是一种肠道细菌,与UC的发展和管理有关.
- 减少AKK丰度与UC严重程度和复发率相关.
研究的目的:
- 审查AKK和UC发病因之间的联系.
- 探索AKK作为UC益生菌的潜力,特别是在儿童中.
- 为UC预防和治疗策略提供见解.
主要方法:
- 对UC患者AKK丰度的临床数据的综述.
- 对研究AKK补充效果的动物研究的分析.
- 检查AKK的菌株特异性益生菌效应.
主要成果:
- AKK增强了肠道屏障的完整性,通过减少炎症和激活抗炎途径来调节免疫反应.
- 降低的AKK水平与UC活动和复发的增加有关.
- 动物研究表明,AKK恢复了粘液层,减少了炎症,并改善了微生物群组成.
- 观察到AKK的菌株特异性影响,其中一些菌株减少了结肠炎,而其他菌株可能会加剧结肠炎.
结论:
- AKK及其代谢物 (例如,SCFA) 显示出作为UC治疗点的前景.
- 仔细的菌株选择对于有效的基于AKK的益生菌疗法至关重要.
- 对于AKK在UC治疗中的临床应用,需要进一步的研究,特别是在儿科患者群体中.
相关概念视频
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
01:29Drugs for Treatment of Ulcerative Colitis in IBD
456
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
456
01:28Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
01:30Peptic Ulcer Disease I: Introduction
742
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
742